Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Boumpas

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2001
Lupus nephritisD T Boumpas
British Journal of Rheumatology|August 1, 1996
A novel action of glucocorticoids--NF-kappa B inhibitionD T Boumpas
Cellular Immunology|July 10, 1996
Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-ATF Paliogianni, D T Boumpas
Transplantation|May 15, 1995
Glucocorticoids regulate calcineurin-dependent trans-activating pathways for interleukin-2 gene transcription in human T lymphocytesF Paliogianni, D T Boumpas
Rheumatic Diseases Clinics of North America|February 1, 1995
Severe major organ involvement in systemic lupus erythematosus. Diagnosis and managementB J Fessler, D T Boumpas
Lupus|July 3, 2004
Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patientsP I Sidiropoulos, D T Boumpas
Seminars in Nephrology|November 1, 1996
Treatment of lupus nephritisH A Austin, D T Boumpas
Annals of the Rheumatic Diseases|May 16, 2006
Differential drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritisP I Sidiropoulos, D T Boumpas
Lupus|January 12, 1999
Outcome criteria for lupus nephritis trials: a critical overviewD T Boumpas, J E Balow
Clinical and Experimental Rheumatology|October 21, 1998
Commonly used disease-modifying antirheumatic drugs in the treatment of inflammatory arthritis: an update on mechanisms of actionC L Danning, D T Boumpas
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2001
Lupus nephritisD T Boumpas
British Journal of Rheumatology|August 1, 1996
A novel action of glucocorticoids--NF-kappa B inhibitionD T Boumpas
Cellular Immunology|July 10, 1996
Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-ATF Paliogianni, D T Boumpas
Transplantation|May 15, 1995
Glucocorticoids regulate calcineurin-dependent trans-activating pathways for interleukin-2 gene transcription in human T lymphocytesF Paliogianni, D T Boumpas
Rheumatic Diseases Clinics of North America|February 1, 1995
Severe major organ involvement in systemic lupus erythematosus. Diagnosis and managementB J Fessler, D T Boumpas
Lupus|July 3, 2004
Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patientsP I Sidiropoulos, D T Boumpas
Seminars in Nephrology|November 1, 1996
Treatment of lupus nephritisH A Austin, D T Boumpas
Annals of the Rheumatic Diseases|May 16, 2006
Differential drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritisP I Sidiropoulos, D T Boumpas
Lupus|January 12, 1999
Outcome criteria for lupus nephritis trials: a critical overviewD T Boumpas, J E Balow
Clinical and Experimental Rheumatology|October 21, 1998
Commonly used disease-modifying antirheumatic drugs in the treatment of inflammatory arthritis: an update on mechanisms of actionC L Danning, D T Boumpas
Pageof 13